mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29275961.
- Also identified by DOI 10.1016/j.cmet.2017.11.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The mechanistic target of rapamycin complex 1 (mTORC1) is a central regulator of metabolic and nutrient cues that integrates environmental inputs into downstream signaling pathways to control cellular metabolism, growth, and survival. While numerous in vitro and in vivo studies reported the positive functions of mTORC1 in the regulation of β cell survival and proliferation under physiological conditions, more recent work demonstrates the opposite in the long term; this is exemplified by the constitutive inappropriate hyper-activation of mTORC1 in diabetic islets or β cells under conditions of increased β cell stress and metabolic demands. These recent findings uncover mTORC1's importance as an emerging significant player in the development and progression of β cell failure in type 2 diabetes and suggest that mTORC1 may act as a "double edge sword" in the regulation of β cell mass and function in response to metabolic stress such as nutrient overload and insulin resistance.
Medical subject headings
- Diabetes Mellitus, Type 2
- Insulin-Secreting Cells
- Mechanistic Target of Rapamycin Complex 1
- Signal Transduction